Search - tctmd.com

Displaying 541 - 560 of 692

Sort: Relevancy | Date

Presentation TCT 2016

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Presenter: Donald Cutlip, Christian Hengstenberg, David E. Kandzari

October 31, 2016

Presentation TCT 2016

Severe AS and COPD

Presenter: Howard C. Herrmann, Vinod H. Thourani, Kendra J. Grubb

October 31, 2016

Presentation TCT 2016

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Presenter: Donald Cutlip, Christian Hengstenberg, Sigmund Silber

October 31, 2016

Presentation TCT 2016

Low-gradient AS Diagnosis and Management

Presenter: Howard C. Herrmann, Vinod H. Thourani, Allan Schwartz

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, David G. Rizik

October 31, 2016

Presentation TCT 2016

Severe AS With a Small Aortic Annulus

Presenter: Howard C. Herrmann, Vinod H. Thourani, Josep Rodés-Cabau

October 31, 2016

Presentation TCT 2016

Severe AS and LV Dysfunction

Presenter: Howard C. Herrmann, Vinod H. Thourani, G. Michael Deeb

October 31, 2016

Presentation TCT 2016

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Presenter: Donald Cutlip, Christian Hengstenberg, Michael Joner

October 31, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Lars Sondergaard

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Davide Capodanno

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, John D. Carroll

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Helene Eltchaninoff

October 30, 2016

Presentation TCT 2016

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, C. Michael Gibson

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Corrado Tamburino

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Neil E. Moat

October 30, 2016

Presentation TCT 2016

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Bernard J. Gersh

October 30, 2016

Presentation TCT 2016

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Presenter: Jeffrey J. Popma, E. Murat Tuzcu, Thomas Walther

October 30, 2016

Presentation TCT 2016

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Jorge Gaspar, Anthony H. Gershlick

October 30, 2016

Presentation TCT 2016

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Presenter: George S. Hanzel, Antoine Lafont, Michael A. Fifer

October 30, 2016

Presentation TCT 2016

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Presenter: George S. Hanzel, Antoine Lafont, Carey D. Kimmelstiel

October 30, 2016

Advertisement

The Newest Durable Polymer-Based DES: BioNir and Outcomes From Nireus Phase II and Bionics Pivotal Trials

Severe AS and COPD

Can Passive Coatings Make a Difference: Results With the COBRA PzF Nanocoated Coronary Stent

Low-gradient AS Diagnosis and Management

Evolution of Durable PolymerBased DES: Clinical Perspectives on Design, Safety, and Efficacy

Severe AS With a Small Aortic Annulus

Severe AS and LV Dysfunction

Evolution of Durable PolymerBased DES: Pathologic Perspectives on Design, Safety, and Efficacy

Key Contributions to TAVR Clinical Research VI: Updates From the NOTION Randomized All-Comers Trial

Rationale for and Design of ABSORB IV (Five-Year Results): What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research V: Updates From U.S. TVT Registry Newest Findings

Key Contributions to TAVR Clinical Research IV: Updates From FRANCE 2 Registry

Rationale for and Design of TWILIGHT and GLOBAL LEADERS: What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research III: Updates From Italian Registries and OBSERVANT

Key Contributions to TAVR Clinical Research II: Updates From the UK TAVR Registry

Rationale for and Design of ISCHEMIA: What I Expect the Findings to Be But What Wont Surprise Me!

Key Contributions to TAVR Clinical Research I: Updates From GARY and Other German Registries

Rationale for and Design of COMPLETE: What I Expect the Findings to Be But What Wont Surprise Me!

Future Therapy for Symptomatic HCM Patients With and Without Dynamic Obstruction

Debate: Surgery, Septal Ablation or New Medical Therapy for Obstructive HCM - Septal Ablation Is As Good As Surgery and Less Invasive!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content